Melhores Transplante de medula óssea Transplante de medula óssea em Israel - TOP-24 médicos

O Dr. Ram Ron é especialista em transplante de medula óssea, com vasta experiência adquirida no Sourasky Medical Center.

• Mais de 25 anos de experiência em tratamentos médicos
• Especialização em Obstetrícia e Ginecologia – Medicina da Reprodução
• Fellowship (Bolsa de Estudo Avançado) do Ronald O Perelman and Claudia Cohen Centre

O Dr. Ron Ram realizou várias centenas de transplantes de células-tronco e é certificado pelo conselho em Medicina Interna, Hematologia e Oncologia Médica no Sourasky Medical Center.

• Concluiu um fellowship em Hematologia e Oncologia no New York Medical College
• Publicou mais de 30 artigos científicos sobre hematologia e oncologia
• Foi autor de um capítulo em um livro didático médico
• Vasta experiência acadêmica e clínica em transplante de medula óssea

Mais de 300 transplantes de medula óssea e sangue do cordão umbilical – Dr. El Hasid lidera os cuidados de transplante pediátrico no Hospital Infantil Dana Dwek.

• Chefe de Onco-hematologia e Oncologia Pediátrica no Sourasky Medical Center
• Membro da American Association for Hematology
• Formado no City of Hope Hospital em Los Angeles
• Publicou 50 artigos de pesquisa sobre transplantes

Dr. Hana Golan, MD, heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation (BMT) Division at Sheba Medical Center. She specializes in childhood cancers, with a focus on neuroblastoma and other high-risk solid tumors.

She leads one of the region’s most advanced pediatric oncology programs. She manages complex, high-risk cases and practices at a hospital ranked in the global top 10.

She is the principal investigator of the High-Risk Neuroblastoma ESIOP protocol. She serves as an investigator in international Phase I/II trials and as the national coordinator of multicenter oncology protocols. She led the development of computerized chemotherapy protocols and patient databases to improve safety.

She earned her MD from the Technion. She completed residencies in pediatrics and pediatric hemato-oncology at Sheba. She conducted advanced research in transplantation immunology at the Weizmann Institute. She is board-certified in Pediatrics and Pediatric Hematology-Oncology. She is a Senior Lecturer at the Sackler Faculty of Medicine, Tel Aviv University. Her research focuses on cancer stem cells, targeted therapies, treatment-resistant malignancies, and cannabinoid-related oncology.

Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.

He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.

He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.

O Dr. Michael Shapira é especialista em transplante de medula óssea no Sourasky Medical Center, acumulando mais de duas décadas de experiência focada.

• Formou-se na Faculdade de Medicina da Universidade Hebraica em 1999
• Especializou-se em medicina interna no Hadassah Medical Center
• Médico sênior em Transplante de Medula Óssea no Hadassah
• Fluente em inglês e hebraico para comunicação clara com o paciente

O Dr. Fredi Aviv traz 31 anos de experiência especializada em onco-hematologia no Sourasky Medical Center (Clínica Ichilov).

• Especializa-se em transplante de medula óssea
• Trabalha em um dos principais centros médicos de Israel
• Vasta experiência com condições hematológicas complexas

O Dr. Dror Levin lidera a hematologia-oncologia pediátrica no Sourasky Medical Center, um dos principais hospitais israelenses para transplantes de medula óssea em crianças.

• Especializa-se no tratamento de câncer ósseo (sarcoma) e distúrbios sanguíneos em crianças
• Formado no Instituto Ortopédico Rizzoli – um líder mundial no tratamento de sarcoma ósseo
• Coordena uma equipe multidisciplinar para o tratamento de sarcoma pediátrico
• Membro da Sociedade Israelense de Hematologia Oncologia Pediátrica (Israel Society of Pediatric Hematology Oncology)

O Dr. Herishanu é especialista em leucemia linfocítica crônica e recebeu múltiplos prêmios por sua pesquisa em hematologia e excelência clínica.

• Treinamento de subespecialidade (Fellowship) realizado no Tel Aviv Medical Center
• Membro das Associações Israelense e Americana de Hematologia
• Ganhador do Prêmio de Oncologia Klitzberg
• Publicou vários artigos na área de hematologia

O Prof. Dr. Reuven Or é um especialista líder em transplante de medula óssea no Hospital Universitário Hadassah Hebrew, tendo sido premiado com o Prémio Menachem Begin pelas suas contribuições.

• Mais de 15 anos de experiência em hematologia e transplante de medula óssea
• Chefe de Hematologia, Imunoterapia do Câncer e Transplante de Medula Óssea em Hadassah
• Diretor Médico do Registro Público de Medula Óssea Hadassah e do Banco Nacional de Sangue Israelita
• Publicou vários artigos em revistas médicas
• Diploma de Doutor em Medicina (MD) pela Universidade de Milão, com pesquisa de pós-doutorado nos EUA

Listado entre os melhores médicos de Israel pela Forbes – Dr. Goldstein é especialista em transplantes de medula óssea pediátricos no Centro Médico Hadassah.

• Chefe de Oncologia Pediátrica e Hemato-Oncologia no Hospital Hadassah Ein Kerem
• Mais de 20 anos dedicados à hemato-oncologia pediátrica e a transplantes haploidênticos
• Membro de múltiplas associações internacionais de oncologia, incluindo a SIOP
• Interesses especiais em retinoblastoma e medicina de precisão

Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.

He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.

He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).

Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.

She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.

Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.

Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.

She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.

Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.

He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.

He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.

Professor Jair Bar, MD, PhD, is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He leads the Thoracic Oncology Unit. He treats lung cancer, including advanced non-small cell cases. His care includes medical oncology, radiotherapy, immunotherapy, and targeted therapy.

He runs a translational research lab focused on resistance to immunotherapy. He has published on exhaled-breath cancer metabolism and on angiogenesis inhibition in lung cancer.

He has chaired the Israel Lung Cancer Group since 2003. He is a member of the Israel Society of Clinical Oncology and Radiotherapy, the American Society of Clinical Oncology, and the American Association for Cancer Research. He is board-certified in Medical Oncology and Radiotherapy Oncology. He is a Senior Lecturer at Tel Aviv University.

Prof. Elad Jacoby, MD, heads the Pediatric Cell Therapy Center at Sheba Medical Center. He is the Medical Director of the Advanced Biotherapy Center. He is a pioneer of pediatric CAR T‑cell therapy in Israel. He led one of the first national leukemia programs. He has almost 20 years of clinical and research experience.

He specializes in CAR T‑cell therapy, bone marrow and stem cell transplantation, and high‑risk pediatric leukemias and lymphomas. He leads international clinical trials and has authored over 240 publications. His collaborations include Johns Hopkins Hospital and the U.S. National Cancer Institute. He is an Associate Professor at Tel Aviv University. He received his MD from Tel Aviv University, completed residency at Sheba Medical Center, and fellowships at Johns Hopkins and the National Cancer Institute. He is board‑certified in Pediatrics and in Pediatric Hematology and Oncology. He serves on the IBFM CAR T‑Cell Taskforce and the Sheba Institutional Review Board. He leads the integration of CAR T‑cell therapy with transplantation.

A Professora Zila Zuckerman é especializada em hematologia e transplante de medula óssea no Centro Médico Rambam.

• Especialização em hematologia e transplantologia
• Qualificações de nível de Professor (titular) na área
• Atua em um centro médico de referência